75 related articles for article (PubMed ID: 12223432)
1. Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection.
Sedjo RL; Roe DJ; Abrahamsen M; Harris RB; Craft N; Baldwin S; Giuliano AR
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):876-84. PubMed ID: 12223432
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women.
Sedjo RL; Inserra P; Abrahamsen M; Harris RB; Roe DJ; Baldwin S; Giuliano AR
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):353-9. PubMed ID: 11927495
[TBL] [Abstract][Full Text] [Related]
3. Hawaii cohort study of serum micronutrient concentrations and clearance of incident oncogenic human papillomavirus infection of the cervix.
Goodman MT; Shvetsov YB; McDuffie K; Wilkens LR; Zhu X; Franke AA; Bertram CC; Kessel B; Bernice M; Sunoo C; Ning L; Easa D; Killeen J; Kamemoto L; Hernandez BY
Cancer Res; 2007 Jun; 67(12):5987-96. PubMed ID: 17553901
[TBL] [Abstract][Full Text] [Related]
4. Combined antioxidant carotenoids and the risk of persistent human papillomavirus infection.
Peterson CE; Sedjo RL; Davis FG; Beam CA; Giuliano AR
Nutr Cancer; 2010; 62(6):728-33. PubMed ID: 20661820
[TBL] [Abstract][Full Text] [Related]
5. The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii.
Goodman MT; Kiviat N; McDuffie K; Hankin JH; Hernandez B; Wilkens LR; Franke A; Kuypers J; Kolonel LN; Nakamura J; Ing G; Branch B; Bertram CC; Kamemoto L; Sharma S; Killeen J
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):537-44. PubMed ID: 9641499
[TBL] [Abstract][Full Text] [Related]
6. Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States).
Sedjo RL; Papenfuss MR; Craft NE; Giuliano AR
Cancer Causes Control; 2003 May; 14(4):319-26. PubMed ID: 12846362
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
8. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
9. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents.
Samoff E; Koumans EH; Markowitz LE; Sternberg M; Sawyer MK; Swan D; Papp JR; Black CM; Unger ER
Am J Epidemiol; 2005 Oct; 162(7):668-75. PubMed ID: 16120706
[TBL] [Abstract][Full Text] [Related]
10. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor axis and oncogenic human papillomavirus natural history.
Harris TG; Burk RD; Yu H; Minkoff H; Massad LS; Watts DH; Zhong Y; Gange S; Kaplan RC; Anastos K; Levine AM; Moxley M; Xue X; Fazzari M; Palefsky JM; Strickler HD
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):245-8. PubMed ID: 18199731
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of human papillomavirus infections.
Baseman JG; Koutsky LA
J Clin Virol; 2005 Mar; 32 Suppl 1():S16-24. PubMed ID: 15753008
[TBL] [Abstract][Full Text] [Related]
13. Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border.
Giuliano AR; Papenfuss M; Abrahamsen M; Inserra P
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):930-4. PubMed ID: 12223441
[TBL] [Abstract][Full Text] [Related]
14. High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia.
Goffin F; Mayrand MH; Gauthier P; Alobaid A; Lussier C; Provencher D; Drouin P; Franco EL; Coutlée F
J Med Virol; 2006 Jun; 78(6):814-9. PubMed ID: 16628584
[TBL] [Abstract][Full Text] [Related]
15. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
[TBL] [Abstract][Full Text] [Related]
16. Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan.
Nagata C; Shimizu H; Yoshikawa H; Noda K; Nozawa S; Yajima A; Sekiya S; Sugimori H; Hirai Y; Kanazawa K; Sugase M; Kawana T
Br J Cancer; 1999 Dec; 81(7):1234-7. PubMed ID: 10584887
[TBL] [Abstract][Full Text] [Related]
17. Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students.
Richardson H; Abrahamowicz M; Tellier PP; Kelsall G; du Berger R; Ferenczy A; Coutlée F; Franco EL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1149-56. PubMed ID: 15894665
[TBL] [Abstract][Full Text] [Related]
18. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.
Castellsagué X; Muñoz N
J Natl Cancer Inst Monogr; 2003; (31):20-8. PubMed ID: 12807941
[TBL] [Abstract][Full Text] [Related]
19. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA.
Perrons C; Jelley R; Kleter B; Quint W; Brink N
J Clin Virol; 2005 Apr; 32(4):278-85. PubMed ID: 15780805
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring.
Cuschieri KS; Whitley MJ; Cubie HA
J Med Virol; 2004 May; 73(1):65-70. PubMed ID: 15042650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
